Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

60 Degrees Pharmaceuticals (SXTPW) Return on Assets (2023 - 2025)

Historic Return on Assets for 60 Degrees Pharmaceuticals (SXTPW) over the last 3 years, with Q3 2025 value amounting to 1.47%.

  • 60 Degrees Pharmaceuticals' Return on Assets fell 1100.0% to 1.47% in Q3 2025 from the same period last year, while for Sep 2025 it was 1.47%, marking a year-over-year decrease of 1100.0%. This contributed to the annual value of 1.17% for FY2024, which is 3300.0% down from last year.
  • Per 60 Degrees Pharmaceuticals' latest filing, its Return on Assets stood at 1.47% for Q3 2025, which was down 1100.0% from 1.54% recorded in Q2 2025.
  • 60 Degrees Pharmaceuticals' Return on Assets' 5-year high stood at 0.1% during Q1 2024, with a 5-year trough of 1.75% in Q1 2025.
  • Moreover, its 3-year median value for Return on Assets was 1.21% (2024), whereas its average is 0.95%.
  • Examining YoY changes over the last 5 years, 60 Degrees Pharmaceuticals' Return on Assets showed a top increase of -1100bps in 2025 and a maximum decrease of -16500bps in 2025.
  • Quarter analysis of 3 years shows 60 Degrees Pharmaceuticals' Return on Assets stood at 0.45% in 2023, then tumbled by -168bps to 1.21% in 2024, then dropped by -22bps to 1.47% in 2025.
  • Its Return on Assets was 1.47% in Q3 2025, compared to 1.54% in Q2 2025 and 1.75% in Q1 2025.